Concurrently, PPAR signaling60,61, alongside methoxylated flavonoids’ α-glucosidase inhibition53 and nuciferine’s anti-steatotic effects45,46, addresses dyslipidemia. The gene discussed is PPARA; the disease is metabolic syndrome.